Suchergebnisse - "Burhenne, Jürgen"

PubPharm (17)

1

Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor

enthalten in: International journal of molecular sciences | 2019

von Russo, A. | Paret, C. | Alt, F. | +18

2

Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided

enthalten in: British journal of clinical pharmacology | 2018

von Huppertz, A. | Werntz, L. | Meid, A. | +5

3

Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment

enthalten in: Respiration; international review of thoracic diseases | 2017

von Grünig, E. | Ohnesorge, J. | Benjamin, N. | +8

CommentIn: Respiration. 2018;96(3):302. - PMID 29455195

4

Steady-state pharmacokinetics and metabolism of voriconazole in patients

enthalten in: The Journal of antimicrobial chemotherapy | 2013

von Geist, M. | Egerer, G. | Burhenne, J. | +3

5

Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring

enthalten in: Therapeutic drug monitoring | 2011

von Hassan, A. | Burhenne, J. | Riedel, K. | +4

6

Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis

enthalten in: International journal of antimicrobial agents | 2010

von Burkhardt, O. | Thon, S. | Burhenne, J. | +2

7

Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Hafner, V. | Czock, D. | Burhenne, J. | +6

8

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

enthalten in: British journal of clinical pharmacology | 2009

von Scholz, I. | Oberwittler, H. | Riedel, K. | +4

9

CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole

enthalten in: Journal of clinical pharmacology | 2009

von Weiss, J. | Ten Hoevel, M. | Burhenne, J. | +5

10

Pharmacokinetics, tissue concentrations, and safety of the antifungal agent voriconazole in chickens

enthalten in: Journal of avian medicine and surgery | 2008

von Burhenne, J. | Haefeli, W. | Hess, M. | +1